-
News | 2025.04.22
Tecovirimat is an effective treatment for mpox, in cells culture
The antiviral drug tecovirimat is frequently used to treat mpox. But is it really effective, especially against the new, more pathogenic strain of the virus that has been in circulation since 2024? A study by the Institut Pasteur, recently published in The Lancet Infectious Diseases (1), concludes that it is.
-
Fiche maladie | 2019.10.16
Chikungunya
Chikungunya is a viral disease transmitted to humans by the bite of Aedes albopictus and Aedes aegypti mosquitoes. Although rarely fatal, chikungunya can cause significant pain and debilitating symptoms that affect patients' quality of life. Existing treatments are solely symptomatic. In France, the current conditions in 80% of départements are conducive to the emergence of chikungunya.
-
Document de presse | 2025.09.19
Consumption of food additives during pregnancy: effects on offspring microbiota increase susceptibility to inflammatory diseases
A study conducted in mice by scientists from the Institut Pasteur and Inserm reveals that maternal consumption of dietary emulsifiers can have a negative impact on the gut microbiota of their offspring. These microbiota alterations are thought to significantly increase their risk of developing chronic inflammatory gut disorders and obesity in adulthood. The harmful transgenerational effects of...
-
Événement | 2025.10.08
Open House at the Institut Pasteur, on October 8
On October 8, 2025, the Institut Pasteur will open the doors of its campus in Paris, as part of its annual fundraising event called Pasteurdon. Lab tours, hands-on workshops, storytelling walks, and more (all in French). A day designed for children from 5 to 11 and their families. Free – registration required – limited admissions.
-
Vidéo | 2025.09.23
Leprosy: revelation
What if the history of leprosy had to be rewritten?Nicolás Rascovan, a researcher at the Institut Pasteur, reveals a discovery that challenges everything we thought we knew:In America, Mycobacterium lepromatosis, a bacterium responsible for leprosy, was already circulating more than 1,000 years ago... long before the arrival of Europeans.Ancient DNA analyses, conducted on human remains from...
-
News | 2025.09.22
A new RNA tool is speeding up the fight against sleeping sickness
A new CRISPR-based RNA test detects animal trypanosomes, which helps track parasites that pose a threat to livestock in Africa and monitor the transmission of human-infectious species. This study was conducted by an international consortium led by the Institut Pasteur. Its outcomes are wholly aligned with both the Institut Pasteur's long-standing mission of fighting infectious disease threats and...
-
Fiche maladie | 2023.09.15
Legionellosis
Legionellosis is a collective term for diseases caused by Legionella bacteria, including the potentially fatal Legionnaires' disease. The most common species, Legionella pneumophila, causes a severe lung infection. The recent emergence of the disease can be explained by the affinity of Legionella bacteria for modern water supply systems. Although there is no vaccine for Legionnaires' disease, it...
-
Fiche maladie | 2017.09.28
Tuberculosis
Tuberculosis (TB) is an infectious disease that generally affects the lungs, caused by the Mycobacterium tuberculosis bacterium. It is highly contagious and is spread through the air when infected people cough or sneeze. Although tuberculosis can be fatal, it is often treatable and can be prevented if diagnosed and treated correctly.
-
Article | 2025.02.20
MD-PhD Program
The Institut Pasteur MD-PhD program is designed to bridge the gap between fundamental, applied research and clinical practice, equipping physicians with the skills needed to tackle the increasingly complex healthcare challenges of today. This program offers opportunities for medical students and doctors to improve patient care and in parallel foster innovation in medical sciences.
-
Vidéo | 2025.09.29
immune awakening
What if we could reprogram the death of cancer cells to reawaken the immune system?In this video, Philippe Bousso, a researcher at the Institut Pasteur, explains how we could:stop “silent death”add the missing piece to the alarm systemtrigger cell self-destructionLab results: tumors eliminated in two-thirds of cases.(video in french, English subtitles available)
